The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
MEDx Call for Pratt/SOM Proposals for Pilot Research Projects in Diagnostics and Devices [Duke Internal Funding -- For Duke Faculty Only]
MEDx is a new entity at Duke created to enhance existing ties and foster new interdisciplinary collaborations between the School of Medicine and Pratt School of Engineering to better achieve the two schools’ many shared goals: 1) developing new therapies, diagnostics and devices; 2) accelerating basic science and its translation into clinical practice; 3) creating innovative educational opportunities for students; and 4) improving the quality and effectiveness of patient care.
This seed program is targeted to enhance collaborations between the School of Medicine and Pratt faculty in the area of diagnostics and devices. MEDx is leading a syndicate of highly interdisciplinary partners – The Clinical and Translational Science Award (CTSA), the Duke Institute for Health Innovation (DIHI), the Departments of Medicine, Surgery, Neurosurgery, Orthopedic Surgery and Mechanical Engineering and Materials Science – to fund these pilot projects. The goal of this opportunity is to catalyze the development of collaborative proposals that will lead to external funding within 12 months of completion of this project.
- Faculty from the Schools of Medicine and Engineering should propose a collaborative project as co-investigators that fits under the broad headings of ‘diagnostics’ (from multi-analyte testing platforms to algorithms) or ‘devices’ (from robots to in-vitro sensors). The project lead may be from either School.
- Existing collaborators can compete, but the project proposed must be in a new area of research.
- A funding agency and/or program of interest must be identified as the target of the collaborative research. Internal funding mechanisms, such as Coulter, may be included.
- It is highly desirable that applicants consult with experts from Duke Innovation and Entrepreneurship (https://entrepreneurship.duke.edu/) to articulate the downstream translational path toward commercialization.
This call is open to any project that addresses the development of new diagnostics or devices.
- Deadline to have materials uploaded on the ORS website: February 15, 2016
The intent is to award $50,000 to each of 6 successful proposals. The funding may be used to support fellows, post docs and / or students but not faculty effort.
Use 1-inch margins and the font of your choice must be at least 11pt. The Duke collaborator must assemble the following materials into ONE PDF and upload the package using the ORS Limited Nomination website https://ors.duke.edu/medx-request-proposals-duke-internal-funding-duke-faculty-only by 5pm on February 15, 2016:
- Project Summary – limited to one page. Required sections: Collaborators, Overview, Objectives/Aims, Expected Outcomes, Future Funding Opportunities Envisioned, Budget Amount Requested, Period of Performance
- Project Description – limited to five pages. Required sections: Background, Research Plan & Methods, Timeline & Responsibilities of Collaborators, Team Science Strategy, Scientific Impact, and Path to Commercialization.
- References – An additional page may be included for references.
- Biosketches of PIs – in NIH format, limited to 5 pages per biosketch, with personal statement emphasizing the importance of and the professional preparation for the proposed work.
- Budget Justification – limited to one page. Break down how funds will be allocated between collaborators. Note that indirect costs are not allowed.
- Award Notice: On or about April 1, 2016.
- Project Start Date: On or about April 15, 2016.
- Period of Performance: Projects must propose a realistic end date. A 12-month or shorter project period is desirable, but longer periods of performance will be considered if well justified.
A review panel made up equally of noncompeting researchers and staff from the two Schools (and with representation of the syndicate of sponsors as well as Duke I&E) will review all applications, with scoring based on quality, novelty or innovation, potential for impact on patient care, and an assessment for potential for successful follow-on funding.